Evidence map›Paper›PMID 33682157›Full record

ArticleClinical cardiology2021

Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic.

Vishal N Rao, Michelle D Kelsey, Anita M Kelsey, Stuart D Russell, Robert J Mentz, Manesh R Patel, Marat Fudim

Abstract read
In one paragraph

Article in Clinical cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Health Care Utilization and Death in Patients With Heart Failure During the COVID-19 Pandemic.Mayo Clinic proceedings. Innovations, quality & outcomes · 2023
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vishal N RaoDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0003-3545-4267
Michelle D KelseyDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Anita M KelseyDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Stuart D RussellDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Robert J MentzDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Manesh R PatelDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Marat FudimDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.

Funding

Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
NHLBI NIH HHS T32 HL069749NIH HHS 5T32HL069749-17
6 · The paper itself

Abstract

backgroundCardiovascular disease (CVD) hospitalizations declined worldwide during the COVID-19 pandemic. It is unclear how shelter-in-place orders affected acute CVD hospitalizations, illness severity, and outcomes. HYPOTHESIS: COVID-19 pandemic was associated with reduced acute CVD hospitalizations (heart failure [HF], acute coronary syndrome [ACS], and stroke [CVA]), and worse HF illness severity.

methodsWe compared acute CVD hospitalizations at Duke University Health System before and after North Carolina's shelter-in-place order (January 1-March 29 vs. March 30-August 31), and used parallel comparison cohorts from 2019. We explored illness severity among admitted HF patients using ADHERE ("high risk": >2 points) and GWTG-HF (">10%": >57 points) in-hospital mortality risk scores, as well as echocardiography-derived parameters.

resultsComparing hospitalizations during January 1-March 29 (N = 1618) vs. March 30-August 31 (N = 2501) in 2020, mean daily CVD hospitalizations decreased (18.2 vs. 16.1 per day, p = .0036), with decreased length of stay (8.4 vs. 7.5 days, p = .0081) and no change in in-hospital mortality (4.7 vs. 5.3%, p = .41). HF hospitalizations decreased (9.0 vs. 7.7 per day, p = .0019), with higher ADHERE ("high risk": 2.5 vs. 4.5%; p = .030), but unchanged GWTG-HF (">10%": 5.3 vs. 4.6%; p = .45), risk groups. Mean LVEF was lower (39.0 vs. 37.2%, p = .034), with higher mean LV mass (262.4 vs. 276.6 g, p = .014).

conclusionsCVD hospitalizations, HF illness severity, and echocardiography measures did not change between admission periods in 2019. Evaluating short-term data, the COVID-19 shelter-in-place order was associated with reductions in acute CVD hospitalizations, particularly HF, with no significant increase in in-hospital mortality and only minor differences in HF illness severity.

Indexed as

Communicable Disease ControlAdultAgedCardiovascular DiseasesCOVID-19FemaleHospitalizationHospital MortalityHumansMaleMiddle AgedNorth CarolinaRetrospective StudiesSeverity of Illness Indexcardiovascular diseaseCOVID-19heart failurehospitalizationsmortalityrisk scores

Identifiers

PMID33682157
PMCPMC8119829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.